Product Name:

NebuSelect™ Recombinant Human TRAIL/TNFRSF10

Catalog#:

NBL-240611

Description:

NebuSelect™ Recombinant Human TRAIL/TNFRSF10(Cat#NBL-240611) is expressed in E.coli without tag.It contains Val114-Gly281.

Species:

Human

Expression System:

E.coli

Molecular Weight: 

The protein has a predicted MW of 19.6 kDa same as Bis-Tris PAGE result.

Target Name:

TRAIL/TNFRSF10; Apo-2L; TRAIL; CD253; TNFSF10; Apo-2 ligand; APO2L; TL2

Target Information:

Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is a member of the TNF superfamily that can initiate the apoptosis pathway by binding to its associated death receptors DR4 and DR5. The activation of the TRAIL pathway in inducing tumor-selective apoptosis leads to the development of TRAIL-based cancer therapies, which include recombinant forms of TRAIL, TRAIL receptor agonists, and other therapeutic agents.

Amino Acid Sequence: 

Val114-Gly281

Purity:

＞95%

Formulation:

see COA

Endotoxin:

＜1EU/ug(LAL Method)

Storage: 

4°C for short term. 

-20°C for long term.

To get more information, please contact us freely.